Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma. | Commun Biol | 2024 | 38216635 | PubTator, text mining | PubMed |
| Soluble mannose receptor: A potential biomarker in Gaucher disease. | Eur J Haematol | 2024 | 38200687 | PubTator, text mining | PubMed |
| Biomarkers to discriminate between aseptic loosened and stable total hip or knee arthroplasties: a systematic review. | EFORT Open Rev | 2024 | 38193539 | PubTator, text mining | PubMed |
| Immunomodulatory differences between mesenchymal stem cells from different oral tissues. | Heliyon | 2024 | 38192855 | PubTator, text mining | PubMed |
| Pyroptosis-related signatures predict immune characteristics and prognosis in IPF. | Heliyon | 2024 | 38192798 | PubTator, text mining | PubMed |
| Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. | Biomark Res | 2024 | 38185636 | PubTator, text mining | PubMed |
| Distinguishing features of depression in dementia from primary psychiatric disease. | Discov Ment Health | 2024 | 38175420 | PubTator, text mining | PubMed |
| Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis. | Heliyon | 2024 | 38173501 | PubTator, text mining | PubMed |
| Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy. | Eur J Med Res | 2024 | 38173048 | PubTator, text mining | PubMed |
| Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer. | Cell Commun Signal | 2024 | 38167013 | PubTator, text mining | PubMed |
| LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p. | Heliyon | 2024 | 38163156 | PubTator, text mining | PubMed |
| Integrative analysis reveals chemokines CCL2 and CXCL5 mediated shear stress-induced aortic dissection formation. | Heliyon | 2024 | 38163105 | PubTator, text mining | PubMed |
| Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis. | Allergy | 2024 | 38108208 | PubTator, text mining | PubMed |
| SPP1+ TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma. | Cancer Gene Ther | 2024 | 38052857 | PubTator, text mining | PubMed |
| LINC00319: Unraveling the spectrum from gene regulation to clinical applications in cancer progression. | Gene | 2024 | 38042213 | PubTator, text mining | PubMed |
| Tumor-derived microparticles promoted M2-like macrophages polarization to stimulate osteosarcoma progression. | Int J Biochem Cell Biol | 2024 | 37956954 | PubTator, text mining | PubMed |
| Decoding Macrophage Subtypes to Engineer Modulating Hydrogels for the Alleviation of Intervertebral Disk Degeneration. | Adv Sci (Weinh) | 2024 | 37939288 | PubTator, text mining | PubMed |
| Calcium-based biomaterials: Unveiling features and expanding applications in osteosarcoma treatment. | Bioact Mater | 2024 | 37920827 | PubTator, text mining | PubMed |
| The ability of biomarkers to assess the severity of atopic dermatitis. | J Allergy Clin Immunol Glob | 2024 | 37915726 | PubTator, text mining | PubMed |
| Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response. | Gastric Cancer | 2024 | 37874427 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=15